Companies/JP/4512

WAKAMOTO PHARMACEUTICAL CO.,LTD. · わかもと製薬株式会社

Income flow

Annual
4512 ANNUAL Income StatementPeriod 2026-03-31Source ANNUAL
Services & otherJPY 10BReal Estate LeasingJPY 192MRevenueJPY 10B+27% Y/YGross profitJPY 5B+31% Y/YCost of revenueJPY 5BOperating profitJPY 256MOperating expensesJPY 4BNet profitJPY 227M+253% Y/YTaxJPY 29MSG&AJPY 4BR&D & otherJPY 1,000

As-filed revenue segments and annual P&L (gross, opex, tax, net). Layout inspired by SankeyArt finance diagrams.

Revenue mix

2026-03-31 · ANNUAL · JPY
By activity
By activityJPY 192M
  • Real Estate LeasingJPY 192M100.0%

Capital & dividends

YieldTrailing twelve-month dividends as a percent of the current share price (income yield).1.17%5y avgAverage dividend yield over the past five years — a smoother view than the latest print.1.12%Trailing DPSCash dividends paid per share over the last twelve months (dividend per share, trailing).0PayoutShare of earnings paid out as dividends. Higher means more income returned; lower leaves more for reinvestment.53.5%Shares outTotal shares currently outstanding (issued and not retired).34.7MFloatShares available to trade — outstanding minus closely held (insiders, strategic holders).16.5M
Upcoming dividend
Next ex-div
2027-03-30 · declared
Last cash
3.5 · 2027-03-30